Akash Garg

Mr. Akash Garg

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AGAkash Garg
Akash Garg
RARutvi Agrawal
Rutvi Agrawal
CCChetan Singh Chauhan
Chetan Singh Chauhan
RDRohitas Deshmukh
Rohitas Deshmukh

6 December 2023 in Heliyon
Verified
Journal Article
Open access
AGAkash Garg
Akash Garg
WLWen-Cheng Lai
Wen-Cheng Lai
HCHimansu Chopra
Himansu Chopra
RARutvi Agrawal
Rutvi Agrawal
TSTalever Singh
Talever Singh
BDBraj Nandan Dubey
Braj Nandan Dubey
The complicated chemical reactions involved in the production of the newer drug delivery systems have mainly impeded efforts to build successful targeted drug delivery systems for a prolonged duration of time. Nanosponges, a recently created colloidal system, have the potential to overcome issues with medication toxicity, decreased bioavailability, and drug release over a wide area because they can be modified to work with both hydrophilic and hydrophobic types of drugs. Nanosponges are small sized with a three-dimensional network having a porous cavity. They can be prepared easily by crosslinking cyclodextrins with different compounds. Due to Cyclodextrin's outstanding biocompatibility, stability, and safety, a number of Cyclodextrin-based drug delivery systems have been developed promptly. The nanosponge drug delivery system possesses various applications in various ailments such as cancer, autoimmune diseases, theranostic applications, enhanced bioavailability, stability, etc. This review elaborates on benefits and drawbacks, preparation techniques, factors affecting their preparation, characterization techniques, applications, and most current developments in nanosponges.

28 June 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RARutvi Agrawal
Rutvi Agrawal
PJPriyanka Jurel
Priyanka Jurel
RDRohitas Deshmukh
Rohitas Deshmukh
RHRanjit Kumar Harwansh
Ranjit Kumar Harwansh
AGAkash Garg
Akash Garg
VKVinoth Kumarasamy
Vinoth Kumarasamy
Since the earliest days, people have been employing herbal treatments extensively around the world. The development of phytochemical and phytopharmacological sciences has made it possible to understand the chemical composition and biological properties of a number of medicinal plant products. Due to certain challenges like large molecular weight and low bioavailability, some components of herbal extracts are not utilized for therapeutic purposes. It has been suggested that herbal medicine and nanotechnology can be combined to enhance the benefits of plant extracts by lowering dosage requirements and adverse effects and increasing therapeutic activity. Using nanotechnology, the active ingredient can be delivered in an adequate concentration and transported to the targeted site of action. Conventional therapy does not fulfill these requirements. This review focuses on different skin diseases and nanotechnology-based herbal medicines that have been utilized to treat them.

1 June 2024 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PDF file
SSShivani Sharma
Shivani Sharma
AGAkash Garg
Akash Garg
RARutvi Agrawal
Rutvi Agrawal
HCHimansu Chopra
Himansu Chopra
DPDevender Pathak
Devender Pathak
Over the past few decades, advancements in nanocarrier-based therapeutic delivery have been significant, and niosomes research has recently received much interest. The self-assembled nonionic surfactant vesicles lead to the production of niosomes. The most recent nanocarriers, niosomes, are self-assembled vesicles made of nonionic surfactants with or without the proper quantities of cholesterol or other amphiphilic molecules. Because of their durability, low cost of components, largescale production, simple maintenance, and high entrapment efficiency, niosomes are being used more frequently. Additionally, they enhance pharmacokinetics, reduce toxicity, enhance the solubility of poorly water-soluble compounds, & increase bioavailability. One of the most crucial features of niosomes is their controlled release and targeted diffusion, which is utilized for treating cancer, infectious diseases, and other problems. In this review article, we have covered all the fundamental information about niosomes, including preparation techniques, niosomes types, factors influencing their formation, niosomes evaluation, applications, and administration routes, along with recent developments.

20 February 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RDRohitas Deshmukh
Rohitas Deshmukh
VSVaibhav Singh
Vaibhav Singh
RHRanjit Kumar Harwansh
Ranjit Kumar Harwansh
RARutvi Agrawal
Rutvi Agrawal
AGAkash Garg
Akash Garg
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati
Prostate cancer is one of the most life-threatening disorders that occur in males. It has now become the third most common disease all over the world, and emerging cases and spiking mortality rates are becoming more challenging day by day. Several approaches have been used to treat prostate cancer, including surgery, radiation therapy, chemotherapy, etc. These are painful and invasive ways of treatment. Primarily, chemotherapy has been associated with numerous drawbacks restricting its further application. The majority of prostate cancers have the potential to become castration-resistant. Prostate cancer cells exhibit resistance to chemotherapy, resistance to radiation, ADT (androgen-deprivation therapy) resistance, and immune stiffness as a result of activating tumor-promoting signaling pathways and developing resistance to various treatment modalities. Nanomedicines such as liposomes, nanoparticles, branched dendrimers, carbon nanotubes, and quantum dots are promising disease management techniques in this context. Nanomedicines can target the drugs to the target site and enhance the drug’s action for a prolonged period. They may also increase the solubility and bioavailability of poorly soluble drugs. This review summarizes the current data on nanomedicines for the prevention and treatment of prostate cancer. Thus, nanomedicine is pioneering in disease management.

21 December 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AGAkash Garg
Akash Garg
KSKamal Shah
Kamal Shah
CCChetan Singh Chauhan
Chetan Singh Chauhan
RARutvi Agrawal
Rutvi Agrawal